Managing COVID-19 disease in pediatric patients

Ei Ye Mon; Yamini Mandelia

doi:10.3949/ccjm.87a.ccc022

Managing COVID-19 disease in pediatric patients

Cleve Clin J Med. 2021 Feb 19. doi: 10.3949/ccjm.87a.ccc022. Online ahead of print.

Authors

Ei Ye Mon¹, Yamini Mandelia²

Affiliations

¹ Department of Primary Care Pediatrics, Pediatric Institute, Cleveland Clinic yemone@ccf.org.
² Center for Pediatric Infectious Diseases, Pediatric Institute, Cleveland Clinic.

PMID: 32393595
DOI: 10.3949/ccjm.87a.ccc022

Abstract

Children are less likely to be infected with SARS-CoV-2 than adults and often have a milder course of COVID-19 disease and a lower case fatality rate. Children account for an estimated 1% to 8% of those diagnosed with COVID-19. Even so, preschool-aged children, infants, and children with underlying health conditions may still be at risk for severe disease and complications. Unique aspects of COVID-19 presentation and disease course in children and possible vertical transmission to newborns from COVID-19-positive mothers are discussed.